Likewise, no association was observed after further restriction to KRAS wild-type metastatic colorectal cancer patients (Fig. S1); albeit somewhat attenuated, a moderate degree of heterogeneity remained between studies (I2 = 44.0%). This evidence concerns the gene KRAS and colorectal cancer.